subject area of
- A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205 Academic Article
- A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer Academic Article
- Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial Academic Article
- Actions of the muscle relaxant chandonium iodide on guinea-pig ileum and vas deferens preparations Academic Article
- Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial Academic Article
- Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer Academic Article
- Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline Academic Article
- Oral Contraceptives and the Risk of Venous Thromboembolism: An Update Academic Article
- Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review Academic Article